AHR and cancer: Even though the tryptophan pathway represents a promising target for the treatment of cancer, downstream signalling pathways, including aryl hydrocarbon receptor activation, have previously caused diverse biological consequences in various malignancies, which may result in either pro‐ or anti‐metastatic effects.